Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is one of the most malignant types of cancer with soaring incidence rates worldwide, attributed to its heterogeneity and complex etiology. Evidently, alternative anti-cancer therapies comprising traditional medicines and natural products have gained attention for t...
Main Authors: | Rasha Irshad, Nafis Raj, Gamal A. Gabr, Nikhat Manzoor, Mohammad Husain |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1018974/full |
Similar Items
-
Pharmacological Features of 18β-Glycyrrhetinic Acid: A Pentacyclic Triterpenoid of Therapeutic Potential
by: Pottathil Shinu, et al.
Published: (2023-03-01) -
versatility of 18β-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders
by: Mohamad Siddiq Bin Mohamad, et al.
Published: (2023-02-01) -
Anti-Photoaging Effects of Nanocomposites of Amphiphilic Chitosan/18β-Glycyrrhetinic Acid
by: Weiyan Quan, et al.
Published: (2023-05-01) -
18β-Glycyrrhetinic acid derivative-based metallo-hydrogels with highly selective and sensitive for histidine detection
by: Kaize Su, et al.
Published: (2023-06-01) -
Glycyrrhetinic acid inhibits non-small cell lung cancer via promotion of Prdx6- and caspase-3-mediated mitochondrial apoptosis
by: Qiuyan Guo, et al.
Published: (2024-04-01)